AAOS: Informed Decision Making Ups QoL After Orthopedic Surgery

This article originally appeared here.
Share this content:
AAOS: Informed Decision Making Ups QoL After Orthopedic Surgery
AAOS: Informed Decision Making Ups QoL After Orthopedic Surgery

TUESDAY, March 14, 2017 (HealthDay News) -- Patients meeting criteria for informed, patient-centered (IPC) decisions have significantly better quality of life after orthopedic surgery, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 14 to 18 in San Diego.

Karen Sepucha, Ph.D., from Massachusetts General Hospital in Boston, and colleagues conducted a prospective cohort study for patients with knee or hip osteoarthritis, lumbar herniated disc, or lumbar spinal stenosis. Patients were surveyed one week after an initial visit with a specialist; patients were sent a follow-up survey six months after the visit or six months after surgery.

The researchers found that 36.0 percent of the patients met the criteria for IPC decisions; across all topics, patients who made IPC decisions had significantly better overall and disease-specific quality of life. In unadjusted analyses, there were increases of 0.06 for the EuroQ-5D, 4.72 for Knee injury and Osteoarthritis Outcome Score symptoms, 2.93 for Harris Hip Score, and −7.59 for the Oswestry Disability Index. IPC decision making correlated with being more likely to be extremely satisfied with pain (76.68 versus 41.86 percent; P = 0.0003), very or extremely satisfied with treatment (70.68 versus 34.66 percent; P = 0.0003), and having less regret (5.2 versus 15.0 percent; P = 0.0006).

"Evidence from this study suggests that well-informed patients who receive their preferred treatment have higher satisfaction and small improvements in health outcomes," the authors write.

Abstract
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

FDA Approves Ocrevus to Treat Severe Form of ...

First drug sanctioned in United States for primary progressive multiple sclerosis

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Study Explores Links Between Zika, GBS, Microcephaly in ...

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly

Inadvertent HPV Vax Doesn't Up Risk of Poor Pregnancy Outcomes

Inadvertent HPV Vax Doesn't Up Risk of Poor ...

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA

is free, fast, and customized just for you!

Already a member?

Sign In Now »